Introduction {#sec1-1}
============

Thalassemia is prevalent in India.\[[@ref1]\] Around 3.4% are carrier and 7,000--10,000 born with thalassemia per year.\[[@ref2]\] In thalassemia, there is lifelong sequence of blood transfusions and chelation therapy leading to iron overload.\[[@ref3][@ref4]\]

With treatment, life expectancy can be prolonged. However, growth retardation affects quality of life. Many factors including iron overload causes growth delay.\[[@ref5][@ref6]\] High-serum ferritin leads to short stature.\[[@ref7]\] Very few studies have reported problem of growth delay; so, present study is undertaken to determine effects of iron overload on height, body mass index (BMI) and ferritin and to determine correlation of ferritin and growth disorders in these children.

Methodology {#sec1-2}
===========

A crosssectional study was conducted on 70 children age up to 18 years (46 boys, 24 girls) with transfusion dependent thalassemia over a time period of 6 months from January 2019 to June 2019 after taking approval from ethics committee on 22 December 2018. Detailed history is evaluated. The following information is collected from medical records of the patients: demographics (age, gender, age at the time of diagnosis and at first transfusion), anthropometric parameters (weight, height, and BMI), and clinical details (blood transfusion history, last pretransfusion hemoglobin and last serum ferritin level). Serum ferritin is measured by chemi-luminescent micro-particle immunoassay.

Center of disease control and prevention (CDC) growth chart were used for boys and girls to assess their weight, height, and BMI percentiles. BMI is calculated as weight in kg/height in square meters. Short stature is defined as height less than 3^rd^ percentile. Underweight is defined as BMI less than 5^th^ percentile, overweight between 85^th^ and 95^th^ percentile and obese more than 95^th^ percentile.

The inclusion criteria were children aged up to 18 years, diagnosed with thalassemia on the basis of hemoglobin electrophoresis or high-performance liquid chromatography and receiving blood transfusion regularly.

The exclusion criteria were children having congenital disease and chronic illness other than thalassemia (such as malignancy, tuberculosis, chronic hepatitis, congenital heart disease, chronic renal failure, epilepsy, and diabetes mellitus).

Data were collected, managed, edited, entered, and analyzed by statistical package of social sciences (SPSS) software. A descriptive analysis of all patients in the study was performed. Male: female ratio was also computed. The mean, median and range were calculated for various variables. Short stature was computed as per different study characteristics. Receiver operating curve was analyzed for ferritin level and short stature. The level of significance taken for all the statistical test was a *P* value of \< 0.05.

Results {#sec1-3}
=======

In total, 70 children of transfusion-dependent thalassemia were enrolled in the study, which included 46 males and 24 females over a time period of 6 months from January 2019 to June 2019. When we assessed the growth pattern of these children, we found that 46 children (65.71%) had short stature, which included 32 male and 11 female. Among 70 children, 77% were underweight and rest had normal BMI.

Mean serum ferritin in patients with height more than 3^rd^ percentile was 1484.77 μg/L and in height less than 3^rd^ percentile was 1600.74 μg/L. Mean serum ferritin in patients with normal BMI was 1,518.24 μg/L, in underweight it was 2,114.82 μg/L, in overweight it was 1,393.03 μg/L and in obese it was 1810.68 μg/L.

The serum ferritin level, hemoglobin level before transfusion, and transfusion frequency were evaluated in these children. The study revealed mean serum ferritin level was 1,560.9 μg/L, 45.71% have serum ferritin level \> 2,500 μg/L, 65.71% had hemoglobin level of 5--8 g/dL before transfusion, and 52.86% have transfusion frequency twice a month \[[Table 1](#T1){ref-type="table"}\].

###### 

Variables characteristics

  Variable                         Ν                    Percentage (%)
  -------------------------------- -------------------- ----------------
  Ferritin Ievel(μg/L)                                  
  Mean                             1560.987             
  Median                           1212                 
  Range                            9641.9(207-9848.9)   
  \<1000                           16                   22.85%
  1000-2500                        22                   31.42%
  \>2500                           32                   45.71%
  Hemoglobin level before                               
  transfi1sion(g/dl)               2                    2.857%
  \<5                              46                   65.71%
  5-8                              18                   25.71%
  8-10                             4                    5.71%
  \>10                                                  
  Frequency of blood transfusion                        
  Once a month                     25                   35.71%
  Twice a month                    37                   52.86%
  Thrice a month                   1                    1.43%
  Irregular                        7                    10%

On comparison of short stature with study characteristic like sex, age when first diagnosed, average hemoglobin before transfusion, frequency of transfusion, and serum ferritin level, we found a significant correlation between short stature and serum ferritin level (*P* \< 0.05) \[[Table 2](#T2){ref-type="table"}\].

###### 

Short stature based on study characteristic

  Charateristics                    Short stature *n*=46   Normal Stature *n*=24   P value
  --------------------------------- ---------------------- ----------------------- ---------
  Sex                                                                              0.347
  Male                              32                     14                      
  Female                            14                     10                      
  Average hemoglobin level before                                                  0.138
  transfiision                      8.365                  8.867                   
  Mean                              8.75                   8.9                     
  Median Range                      7.2(3.6-10.8)          5.5(6-11.5)             
  Age when firstly diagnosed                                                       0.417
  \<6 months                        7                      5                       
  6month-2year                      28                     15                      
  \>2year                           11                     4                       
  Frequency of blood transfusion                                                   0.412
  Once a month                      14                     11                      
  Twice a month                     25                     12                      
  Thrice a month                    1                      0                       
  Irregular                         6                      1                       
  Ferritin level                                                                   0.006
  Mean                              1600.04                1203.83                 
  SD                                615.37                 432.14                  

Receiver operating characteristics (ROC) curve was prepared to evaluate serum ferritin cut-off point and short stature incidence \[[Figure 1](#F1){ref-type="fig"}, [Table 3](#T3){ref-type="table"}\]. Serum ferritin cut off point was found to be 1,107 μg/L with respect to the incidence of short stature.

![Receiver operating characteristic curve serum ferritin levels with short stature](JFMPC-9-1166-g001){#F1}

###### 

Youden index

  ---------------------- --------
  Youden index J         0.4764
  Associated criterion   \>1107
  Sensitivity            93.48
  Specificity            54.17
  ---------------------- --------

After obtaining the serum ferritin cut-off point, the subjects were divided based on serum ferritin cut-off point. It was analyzed in relation to the incidence of short stature and we observed a significant correlation between serum ferritin level and the incidence of short stature (*P* = 0.001) \[[Table 4](#T4){ref-type="table"}\].

###### 

Analysis between the variables and short stature

  Ferritin value   Short stature   Normal Stature   P value
  ---------------- --------------- ---------------- ---------
  ≤1107 μg/L       3               13               0.001
  \> 1107μg/L      43              11               

The correlation of short stature with serum ferritin level and age was observed in [Table 5](#T5){ref-type="table"} and we found a statistically significant correlation between serum ferritin level and short stature (*P* \< 0.05), whereas it was not significant with age.

###### 

Analysis between the variables and short stature (Logistic regression)

             B        S.E.   95% C.I.for EXP(B)   
  ---------- -------- ------ -------------------- -------
  Age        -.064    .062   .830                 1.060
  Ferritin   -0.002   .001   0.996                0.999

Discussion {#sec1-4}
==========

Thalassemia poses a challenge to health and it drastically reduces the quality of life. However, with optimal treatment, the quality of life and life expectancy of these patients can be improved. Other factors in thalassemia that affect growth disorders are decreased level of pretransfusion hemoglobin, high-serum ferritin level, suboptimal use of iron chelator, and increasing age of thalassemic children. Thalassemic children grow normally in first decade of life but growth retardation occur after 10 years.\[[@ref8]\]

In total, 70 children of transfusion-dependent thalassemia were enrolled in this study, of which 65% were male and 35% female. The anthropometric data from this study demonstrated growth failure in transfusion-dependent thalassemia secondary to iron overload. As age advances, growth impairment increases. As per the growth pattern, we found that 65.71% were short statured and rest had normal height. The proportion of short stature in our study was similar to the previous studies of Jana *et al*.,\[[@ref9]\] Fadlyana *et al*.,\[[@ref10]\] and ParthaSarathiDas *et al*.,\[[@ref11]\] which discovered the incidence of short stature were 65.8%, 62%, and 67%, respectively. The cause of short stature in thalassemic children can be chronic anemia, hypersplenism, and folate deficiency.\[[@ref8]\] Nutritional status was assessed by BMI based on age and we found that 77% of these thalassemic children were underweight which was similar to study of ParthaSarathiDas *et al*.\[[@ref11]\] in which 70% were underweight. Bushra Moiz *et al*.\[[@ref12]\] also noted that 42% were malnourished and obesity was absent in thalassemic children. Yeni *et al*.\[[@ref13]\] found undernutrition in 29.4% and stunting in 58.5% of children. Similarly, Badiger S *et al*.\[[@ref14]\] also observed undernutrition and stunting amongst irregularly transfused thalassemic children. Along with this, they also observed pubertal delay in these children. The pathogenesis of growth failure in thalassemia is multifactorial. One of the major factors is iron overload. Frequent blood transfusions can control hemoglobin level, but if serum ferritin levels are greater than the desired level, patient\'s physical growth can be affected.

Normal growth in thalassemic children can be attained if hemoglobin level is maintained in a range of 10--11 g/dL in first decade of life. In our study, 65.71% children had average hemoglobin level of 5--8 g/dL before transfusion this was almost similar to study of Fadlyana *et al*.\[[@ref10]\] In our study, we did not found any correlation between average hemoglobin level before transfusion and the incidence of short stature (*P* = 0.138). However, in contrast to our study, Al-Wataify.\[[@ref15]\] showed that the average hemoglobin level before transfusion was \<9 g/dL which statistically increases the incidence of short stature. This may be due to lack of compliance to attend regular blood transfusion due to low socioeconomic status and less awareness about the disease in parents.

We found that 45.71% children had high-serum ferritin level. The results were much higher (77%) in study of Fadlyana *et al*.\[[@ref10]\] Serum ferritin value was statistically significant in short stature children (*P* = 0006). Serum ferritin level is influenced by many factors, such as the age at presentation, the age when firstly transfused, and the age when firstly chelated, efficacy of the iron chelation drug, and its compliance. The stature of thalassemic children is associated with higher serum ferritin level.\[[@ref9]\]

In this study, we found a statistically significant correlation between serum ferritin level and the incidence of short stature (*P* = 0.001). This finding was similar (*P* = 0.003) to study of Fadlyana *et al*.\[[@ref10]\] The multivariate analysis to examine the variables showed that serum ferritin level influence the incidence of short stature in thalassemic children, whereas Fadlyana *et al*.\[[@ref10]\] showed that in addition to serum ferritin level, age also influence the incidence of short stature. Shalitin *et al*.\[[@ref16]\] observed that short stature occurred when serum ferritin level were \> 3,000 μg/L. High-serum ferritin level may cause growth retardation.\[[@ref10]\] In our study, we found a correlation between serum ferritin level and the incidence of short stature, which was thought to be due to iron overload in endocrine glands producing growth disorders.

This study remains the first to be conducted in our region, which depicted about the growth pattern and its correlation with serum ferritin level. The limitation of this study was these children were not examined for their sexual development. Since hypogonadism is the major determinant of growth failure in beta thalassemia major, therefore, it leads to progression of growth stunting with advancing age. The effect of other factors such as hormonal status, endocrinopathies on growth and their exact association with serum ferritin level need to be assessed in a meticulous manner. This could not be done in this study due to the expensive cost of hormonal testing.

It is not only important to transfuse the packed red blood cells to maintain hemoglobin level for proper growth and development of the children affected with thalassemia but also it is of utmost importance for the primary care givers to monitor the iron status of these patients with the help of serum ferritin level. As high-serum iron and serum ferritin will be equally detrimental and will lead to growth faltering.

Hence to conclude, regular blood transfusions can maintain pretransfusion hemoglobin level, but if serum ferritin levels are higher than the desired level, patient\'s physical growth can be affected. There was significant correlation between serum ferritin level and short stature in thalassemic children. Thalassemia patients requiring regular blood transfusion need better strategies for removing excess iron from their body. Thus, along with maintaining hemoglobin level, it is important to have effective iron chelation therapy to minimize retardation of growth in patient with transfusion-dependent thalassemia.
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